Advanced glycation end products as an upstream molecule triggers ROS-induced sFlt-1 production in extravillous trophoblasts: A novel bridge between oxidative stress and preeclampsia
Authors:
- M. ZhangMZM. Zhang
- M. ZhongMZM. Zhong
- Y.H. YuYYY.H. Yu
- W.Z. LiangWLW.Z. Liang
- L.L. HangLHL.L. Hang
- Y.F. GaoYGY.F. Gao
- L.P. HuangLHL.P. Huang
- Z.J. WangZWZ.J. Wang
Abstract
No abstract availableKeywords
Funding Information
- President Grant from Nanfang Hospital (2012C026)
This publication has 39 references indexed in Scilit:
- Circulating Angiogenic Factors and Urinary Prolactin as Predictors of Adverse Outcomes in Women With PreeclampsiaHypertension, 2013
- Biomarkers in pre-eclampsia: A novel approach to early detection of the diseaseJournal of Obstetrics and Gynaecology, 2012
- A Cross‐Talk of Decidual Stromal Cells, Trophoblast, and Immune Cells: A Prerequisite for the Success of PregnancyAmerican Journal of Reproductive Immunology, 2012
- Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms‐like tyrosine kinase 1 and soluble endoglin in the prediction of pre‐eclampsia: a systematic review and meta‐analysisBJOG: An International Journal of Obstetrics & Gynaecology, 2012
- Trophoblast developmentReproduction, 2012
- Pre-eclampsiaThe Lancet, 2010
- Circulating Angiogenic Factors in Early Pregnancy and the Risk of Preeclampsia, Intrauterine Growth Restriction, Spontaneous Preterm Birth, and StillbirthObstetrics & Gynecology, 2007
- Circulating Angiogenic Factors and Placental AbruptionObstetrics & Gynecology, 2006
- Hypoxia and sFlt-1 in Preeclampsia: The “Chicken-and-Egg” QuestionEndocrinology, 2004
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004